Emailing Patient Information

October 9, 2003

Rheumatology MedPulse®

www.medscape.com/rheumatologyhome

MedPulse is a weekly index of key news and features on Medscape's specialty sites compiled by Medscape's Editors.

New Horizons in TNF Inhibition: Targeting Psoriatic Arthritis

CME Audioconference Series

October 9 at 12:00 pm ET

October 7, 8, 9, and 13 at 7:00 pm ET

Playback option begins on October 14, 2003

Please call 1- from 8:00am to 8:00pm ET to register. Be sure to specify the date/time for which you wish to participate.

ALSO IN THIS ISSUE:NEWSMEMBER NEWSUSER SUPPORT

NEW FEATURES THIS WEEK

INSTANT POLL

Requirements for Email of Patient Information

In a Medscape Instant Poll that launched Sept. 30, 81% of respondents said they think that federal regulations require that email exchanges of patient information with other clinicians and insurers be conducted using a secure communications system. But 18% said they think it is not required. As of Oct. 2, a total of 518 respondents had taken part in this poll. To view the full results of the poll, which ended on Oct. 8, click on the title above.

RESOURCE CENTERS

Rheumatoid Arthritis

Browse this collection of Medscape's key clinical content on rheumatoid arthritis.

MORE THIS WEEK

V gamma-9/V delta-2 T Lymphocytes in Italian Patients With Behcet's Disease: Evidence for Expansion, and Tumour Necrosis Factor Receptor II and Interlukin-12 Receptor B1 Expression in Active Disease

V gamma-9/V delta-2 T cell activation is correlated with disease progression and probably involved in the pathogenesis.Arthritis Res Ther 5(5) 2003

Differentiation of Naive CD4+ T Cells Towards T Helper 2 Cells is Not Impaired in Rheumatoid Arthritis Patients

The perpetuation of arthritogenic T-cell activity in RA seems not to be the result of intrinsic defects of naive CD4+ T cells to develop towards suppressive memory Th2 cells.Arthritis Res Ther 5(5) 2003

Update on Juvenile Dermatomyositis: New Advances in Understanding Its Etiopathogenesis

This article focuses on advances made in understanding the role that complement, soluble adhesion molecules, thrombospondin-1 levels, and genetics play in the evolution of juvenile dermatomyositis.Curr Opin Rheumatol 15(5) 2003

MAST CELLS AND RHEUMATOID ARTHRITIS

The mast cell could become a potential target in therapeutic intervention for RA. Read "High CXCR3 Expression in Synovial Mast Cells Associated With CXCL9 and CXCL10 Expression in Inflammatory Synovial Tissues of Patients With Rheumatoid Arthritis." NEW in the "Focus On" section of the Rheumatoid Arthritis Resource Center.

NEWS

NEWS CME

Topical Cold Gel Effective in Sports Injuries

In a prospective, randomized, double-blind trial, this gel reduced pain and decreased disability of soft tissue injuries more rapidly than did placebo gel.Medscape Medical News 2003

MORE NEWS THIS WEEK

Leflunomide Dosing for RA Inadequate for Some Patients

With current dosing strategies, leflunomide inefficacy results in earlier discontinuation of treatment than other disease-modifying antirheumatic drugs (DMARDs) used to treat rheumatoid arthritis (RA), Austrian investigators report.Reuters Health Information 2003

NIH Director Takes Overhaul Plan to Congress

The head of the National Institutes of Health took his "roadmap" to overhaul the management of the nation's pre-eminent biomedical research establishment to the US Congress Thursday. But as usual, lawmakers -- who have doubled NIH's budget over the past five years to more than $27 billion -- have some ideas of their own for how the agency needs to change.Reuters Health Information 2003

MEMBER NEWS

COMPREHENSIVE, PRINTABLE DRUG INFORMATION

Medscape DrugInfo provides clinical information on drug indications, adverse effects, interactions, and other cautionary guidance, as well as handouts for your patients. Click DrugInfo from the top of any page, or search by drug name.

Sign In

Emailing Patient Information

Recommended Posts

Guest guest

Link to comment

Share on other sites

Join the conversation

Activity